14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CRBP ranks #16429 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Corbus Pharmaceuticals Holdings Stock Forecast NASDAQ:CRBP

$0.51 (1.58%)

Volume: 772k

Closed: Jan 19, 2022

Hollow Logo Score: -4.441

Corbus Pharmaceuticals Holdings Stock Forecast

$0.51 (1.58%)

Volume: 772k

Closed: Jan 19, 2022

Score Hollow Logo -4.441

Corbus Pharmaceuticals Holdings Company Profile

100 River Ridge Drive

Norwood MA 02062



Industry: Biotechnology

Sector: Healthcare

Corbus Pharmaceuticals Holdings


Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. Its lead product candidate includes Resunab, a novel oral endocannabinoid-mimetic drug, which is in Phase 2 clinical trials for the treatment of cystic fibrosis, systemic sclerosis, and skin-predominant dermatomyositis diseases. The company is based in Norwood, Massachusetts.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE